drugset / Trial / NCT02823964

EASY: Extended Access to Sollpura Over Years

NCT02823964 ↗

Phase 4 Completed 25 enrolled Anthera Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

Liprotamase consists of 3 soluble, non-porcine digestive enzymes, lipase, protease, and amylase, combined in a fixed ratio. Liprotamase is stable in the stomach and can be formulated without enteric coating for administration either as a capsule or as a dosing solution dissolved in water or juice.

Timeline

Start
2016-09
Primary completion
2018-03
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Liprotamase Protein / enzyme biologic — Oral